Plasma Fractionation Market to Hit $30.53 Billion & Globally at 6.1% CAGR by 2028

Plasma Fractionation Market

Plasma Fractionation Market

Demand for plasma fractionation products owing to surge in prevalence of various medical conditions that require use of plasma derivatives such as hemophilia.

PORTLAND, OR, UNITED STATES, September 15, 2021 /EINPresswire.com/ — Increase in geriatric population, surge in prevalence of rare diseases, rise in usage of immunoglobulins in areas of medicine, and upsurge in number of plasma collection centers drive the growth of the global plasma fractionation market. However, high cost of plasma-derived products hinders the market growth. On the other hand, potential for growth in emerging countries create new opportunities in the market.

"Plasma Fractionation Market by Product (Albumin, Immunoglobulins, and Coagulation Factor VIII), Application (Neurology, Hematology, Immunology, Critical Care and Others), End User (Hospitals, and Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2018–2028." According to the report, the global plasma fractionation market garnered $16.82 billion in 2018, and is estimated to reach $30.53 billion by 2028, growing at a CAGR of 6.1% from 2019 to 2028.

Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/943

The immunoglobulins segment to maintain its lead position during the forecast period:-

Based on product, the immunoglobulins segment contributed to more than two-thirds of the total share of the global plasma fractionation market in 2018, and is expected to maintain its lead position during the forecast period. Moreover, this segment is estimated to register the largest CAGR of 6.7% from 2019 to 2028. This is due to increase in recognition and treatment of immune deficiencies along with rise in the usage of high dose IgG products in the treatment of autoimmune neurologic diseases. The research also discusses segments such as albumin and coagulation factor VIII.

The neurology segment to maintain its leadership position during the forecast period:-

Based on application, the neurology segment held the highest market share of the global plasma fractionation market, accounting for more than two-fifths of the total share in 2018, and is estimated to maintain its leadership position in terms of revenue during the forecast period. Moreover, this segment is estimated to grow at the highest rate with a CAGR of 6.8% from 2019 to 2028. This is due to increase in awareness related to diagnosis and treatment of neurological disorders in animals. The research also analyzes segments including hematology, immunology, critical care, and others.

China (including Taiwan) to present lucrative opportunities:-

Based on country, China (including Taiwan) contributed to the highest market share in terms of revenue, contributing to nearly one-fifth of the global plasma fractionation market in 2018, and is expected to maintain its dominance in terms of revenue during the forecast period. This country is expected to maintain the largest CAGR of 9.2% from 2019 to 2026, owing to huge patient base of disorders such as hemophilia, Von Willebrand disease, and others along with rise in awareness related to blood donations.

Inquiry for Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/943

Leading market players:-

• Grifols SA
• Baxter International Inc.
• CSL LTD.
• Bio Product Laboratory
• Octapharma AG
• Sanquin
• Laboratoire Franais Du Fractionnement Et Des
• Kedrion
• Biotest
• Takeda Pharmaceuticals

Similar Reports:

Genotyping Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

Live Cell Imaging Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 -503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire